1. Home
  2. CAL vs IPSC Comparison

CAL vs IPSC Comparison

Compare CAL & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Caleres Inc.

CAL

Caleres Inc.

HOLD

Current Price

$13.19

Market Cap

400.3M

ML Signal

HOLD

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$2.19

Market Cap

399.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAL
IPSC
Founded
1878
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
400.3M
399.0M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
CAL
IPSC
Price
$13.19
$2.19
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$15.00
$4.25
AVG Volume (30 Days)
528.2K
1.1M
Earning Date
05-28-2026
05-14-2026
Dividend Yield
2.08%
N/A
EPS Growth
N/A
91.30
EPS
N/A
N/A
Revenue
$85,513,000.00
$109,164,000.00
Revenue This Year
$5.19
N/A
Revenue Next Year
$2.45
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.46
1556.76
52 Week Low
$8.80
$0.44
52 Week High
$17.53
$2.97

Technical Indicators

Market Signals
Indicator
CAL
IPSC
Relative Strength Index (RSI) 55.12 45.81
Support Level $12.80 $1.87
Resistance Level $13.55 $2.67
Average True Range (ATR) 0.57 0.16
MACD -0.02 -0.02
Stochastic Oscillator 32.63 8.16

Price Performance

Historical Comparison
CAL
IPSC

About CAL Caleres Inc.

Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

Share on Social Networks: